© Provided by Health.com There's still a lot to learn about this new variant.
What is the Mu variant, exactly?
The Mu variant was first identified in Colombia in January 2021, according to the WHO. Since that time, there have been some scattered cases, as well as reports of larger outbreaks, around the world, including in other areas of South America, the UK, Europe, the US, and Hong Kong.
As a variant of interest, Mu has "a constellation of mutations that indicate potential properties of immune escape" according to the weekly bulletin from the WHO. In addition, variants of interest are defined as those that have genetic changes that are known to (or are predicted to) affect certain virus characteristics, including disease severity, immune escape, diagnostic or therapeutic escape, and transmissibility, and have been "identified to cause significant community transmission or multiple COVID-19 clusters, in multiple countries with increasing relative prevalence alongside increasing number of cases over time, or other apparent epidemiological impacts to suggest an emerging risk to global public health," according to the WHO. However, the organization also says more research is needed to fully understand Mu and what it's capable of.
How worried should you be about the Mu variant?
This particular variant isn't as widespread at the moment as many other that are listed as "of interest." According to data from the WHO bulletin, it currently makes up less than 0.1% of COVID-19 infections in the world, though rates are higher in certain countries, including Colombia (where it accounts for 39% of cases) and Ecuador (13%).
Worth noting, however: Mu is currently not on the Centers for Disease Control and Prevention's list of variants of interest or variants of concern, at least for the time being.
"It's not very concerning at the present time," William Schaffner, M.D., an infectious disease specialist and professor at the Vanderbilt University School of Medicine, tells Health. He points out that Mu was first detected in January of this year and is only now being named a variant of interest. "Researchers are still assessing how quickly it spreads and what its level of contagiousness is," he says. "It's interesting that it's even reached the level of becoming a variant of interest [with the WHO]."
Infectious disease expert Amesh A. Adalja, M.D., a senior scholar at the Johns Hopkins Center for Health Security agrees that there's no reason to panic over Mu at the moment. " People should not be so worried about this variant," he tells Health. "Variants are continuously being generated."
Dr. Adalja also doesn't think that Mu will overtake the Delta variant. "It's unlikely that it is more fit than Delta and will be able to overtake it," he says.
News
Microplastics found in prostate tumors in small study
In a new study, researchers found microplastics deep inside prostate cancer tumors, raising more questions about the role the ubiquitous pollutants play in public health. The findings — which come from a small study of 10 [...]
All blue-eyed people have this one thing in common
All Blue-Eyed People Have This One Thing In Common Blue Eyes Aren’t Random—Research Traces Them Back to One Prehistoric Human It sounds like a myth at first — something you’d hear in a folklore [...]
Scientists reveal how exercise protects the brain from Alzheimer’s
Researchers at UC San Francisco have identified a biological process that may explain why exercise sharpens thinking and memory. Their findings suggest that physical activity strengthens the brain's built in defense system, helping protect [...]
NanoMedical Brain/Cloud Interface – Explorations and Implications. A new book from Frank Boehm
New book from Frank Boehm, NanoappsMedical Inc Founder: This book explores the future hypothetical possibility that the cerebral cortex of the human brain might be seamlessly, safely, and securely connected with the Cloud via [...]
Deadly Pancreatic Cancer Found To “Wire Itself” Into the Body’s Nerves
A newly discovered link between pancreatic cancer and neural signaling reveals a promising drug target that slows tumor growth by blocking glutamate uptake. Pancreatic cancer is among the most deadly cancers, and scientists are [...]
This Simple Brain Exercise May Protect Against Dementia for 20 Years
A long-running study following thousands of older adults suggests that a relatively brief period of targeted brain training may have effects that last decades. Starting in the late 1990s, close to 3,000 older adults [...]
Scientists Crack a 50-Year Tissue Mystery With Major Cancer Implications
Researchers have resolved a 50-year-old scientific mystery by identifying the molecular mechanism that allows tissues to regenerate after severe damage. The discovery could help guide future treatments aimed at reducing the risk of cancer [...]
This New Blood Test Can Detect Cancer Before Tumors Appear
A new CRISPR-powered light sensor can detect the faintest whispers of cancer in a single drop of blood. Scientists have created an advanced light-based sensor capable of identifying extremely small amounts of cancer biomarkers [...]
Blindness Breakthrough? This Snail Regrows Eyes in 30 Days
A snail that regrows its eyes may hold the genetic clues to restoring human sight. Human eyes are intricate organs that cannot regrow once damaged. Surprisingly, they share key structural features with the eyes [...]
This Is Why the Same Virus Hits People So Differently
Scientists have mapped how genetics and life experiences leave lasting epigenetic marks on immune cells. The discovery helps explain why people respond so differently to the same infections and could lead to more personalized [...]
Rejuvenating neurons restores learning and memory in mice
EPFL scientists report that briefly switching on three “reprogramming” genes in a small set of memory-trace neurons restored memory in aged mice and in mouse models of Alzheimer’s disease to level of healthy young [...]
New book from Nanoappsmedical Inc. – Global Health Care Equivalency
A new book by Frank Boehm, NanoappsMedical Inc. Founder. This groundbreaking volume explores the vision of a Global Health Care Equivalency (GHCE) system powered by artificial intelligence and quantum computing technologies, operating on secure [...]
New Molecule Blocks Deadliest Brain Cancer at Its Genetic Root
Researchers have identified a molecule that disrupts a critical gene in glioblastoma. Scientists at the UVA Comprehensive Cancer Center say they have found a small molecule that can shut down a gene tied to glioblastoma, a [...]
Scientists Finally Solve a 30-Year-Old Cancer Mystery Hidden in Rye Pollen
Nearly 30 years after rye pollen molecules were shown to slow tumor growth in animals, scientists have finally determined their exact three-dimensional structures. Nearly 30 years ago, researchers noticed something surprising in rye pollen: [...]
How lipid nanoparticles carrying vaccines release their cargo
A study from FAU has shown that lipid nanoparticles restructure their membrane significantly after being absorbed into a cell and ending up in an acidic environment. Vaccines and other medicines are often packed in [...]
New book from NanoappsMedical Inc – Molecular Manufacturing: The Future of Nanomedicine
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]















